Contraception
Volume 67, Issue 1 , Pages 33-37 , January 2003

Vitamin D receptor gene polymorphism and bone metabolism during low-dose oral contraceptive use in young women

  • Bojana Pinter

      Affiliations

    • Department of Obstetrics and Gynecology, University Medical Center, Slajmerjeva 3, 1000 Ljubljana, Slovenia
    • Corresponding Author InformationCorresponding author. Tel.: +386-1-522-6060; fax: +386-61-522-6130.
    • ,
  • Andreja Kocijancic

      Affiliations

    • Department of Endocrinology, University Medical Center, Zaloska 7, 1000 Ljubljana, Slovenia
    • ,
  • Janja Marc

      Affiliations

    • Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana, Slovenia
    • ,
  • Lidija Andolsek-Jeras

      Affiliations

    • Slovenian Academy of Sciences and Arts, Novi trg 2, 1000 Ljubljana, Slovenia
    • ,
  • Janez Prezelj

      Affiliations

    • Department of Endocrinology, University Medical Center, Zaloska 7, 1000 Ljubljana, Slovenia

Received 25 March 2002 ,Revised 22 July 2002 ,Accepted 19 August 2002.

References 

  1. Goldsmith F, Johnston O. Bone mineral (effects of oral contraceptives, pregnancy and lactation). J Bone Joint Surg. 1975;57A:657–668
  2. Kleekoper M, Brienza RS, Schultz LR, Johnson CC. Oral contraceptive use may protect against low bone mass. Arch Intern Med. 1991;151:1971–1976
  3. Shargil AA. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound (a three-year prospective study). Int J Fertil. 1985;30:15–28
  4. Kritz-Silverstein D, Barret-Connor E. Bone mineral content in postmenopausal women as determined by prior oral contraceptive use. Am J Public Health. 1993;3:100–102
  5. Volpe A, Silferi M, Genazzani AD, Genazzani AR. Contraception in older women. Contraception. 1993;47:229–239
  6. Volpe A, Amram A, Cagnacci A, Battaglia C. Biochemical aspects of hormonal contraception (effects on bone metabolism). Eur J Contracept Reprod Health Care. 1997;2:123–126
  7. Mazess RB, Barden HS. Bone density in premenopausal women (effects of age, dietary intake, physical activity, smoking and birth-control pills). Am J Clin Nutr. 1991;53:132–142
  8. Rodin A, Chapman MG, Fogelman I. Bone density in users of combined oral contraception (preliminary report of a pilot study). Br Fam Plann. 1991;16:125–129
  9. Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women (risk factors for future osteoporosis?). BMJ. 1989;298:924–928
  10. Garnero P, Sornay-Rendu E, Delmas PD. Decreased bone turnover in oral contraceptive users. Bone. 1995;16:499–503
  11. Kitai E, Blum M, Kaplan B. The bone sparing effect of oral contraceptive use in non-smoking women. Clin Exp Obstet Gynecol. 1992;19:30–33
  12. Mais V, Fruzzeti F, Ajossa S, Paoletti AM, Guerriero S, Melis GB. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol (a prospective study). Contraception. 1993;48:445–452
  13. Polatti F, Perotti F, Filippa N, Gallina D, Nappi RE. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995;51:221–224
  14. Recker RR, Davies KM, Hinders SM, Heany RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA. 1992;268:2403–2408
  15. Dawson-Huges B. Prevention. In:  Riggs BL,  Melton LJ editor. Osteoporosis (etiology, diagnosis, and management). 2nd ed.. Philadelphia, New York: Lippincott-Raven Publishers; 1995;p. 1335–1350
  16. Burr DB, Yoshikawa T, Teegarden D, et al.  Exercise and oral contraceptive use suppress the normal age-related increase in bone mass and strength of the femoral neck in women 18–31 years of age. Bone. 2000;27:855–863
  17. Heaney RP, Matkovic V. Inadequate peak bone mass. In:  Riggs BL,  Melton LJ editor. Osteoporosis (etiology, diagnosis, and management). 2nd ed.. Philadelphia, New York: Lippincott-Raven Publishers; 1995;p. 115–131
  18. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability (vitamin D receptor gene polymorphism and circulating osteocalcin). Proc Natl Acad Sci USA. 1992;89:6665–6669
  19. Morrison NA, Qi JC, Tokita A, et al.  Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284–287
  20. Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B. The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopusal black and white women. J Bone Miner Res. 1995;10:985–990
  21. Howard G, Nguyen T, Morrison N, et al.  Genetic influences on bone density (physiological correlates of vitamin D receptor gene alleles in premenopausal women). J Clin Endocrinol Metab. 1995;80:2800–2805
  22. Howard G, Nguyen T, Morrison N, et al.  Genetic influences on bone density (physiological correlates of vitamin D receptor gene alleles in premenopausal women. Notification of genotype corrections). J Clin Endocrinol Metab. 1998;83:1043
  23. Salamone LM, Ferrell R, Black DM, et al.  The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporos Int. 1996;6:63–68
  24. Gennari L, Becherini L, Masi L, et al.  Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women (evidence of multiple gene contribution to bone mineral density). J Clin Endocrinol Metab. 1998;83:939–944
  25. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjourm JP. Vitamin-D-receptor-gene polymorphism and change in lumbar-spine bone mineral density. Lancet. 1995;345:423–424
  26. Marc J, Prezelj J, Komel R, Kocijancic A. Association of vitamin D receptor gene polymorphism with bone mineral density in Slovenian postmenopausal women. Gynecol Endocrinol. 2000;14:60–64
  27. Riggs BL, Nguyen TV, Melton LJ, et al.  The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res. 1995;10:991–996
  28. Ferrari SL, Rizzoli R, Slosman DO, Bonjuour JP. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?. J Bone Miner Res. 1998;13:363–370
  29. Sainz J, van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V. Vitamin D receptor gene polymorphism and bone density in prepubertal American girls of Mexican descent. N Engl J Med. 1997;337:77–82
  30. Tao S, Tony Y, Garnett S, et al.  Vitamin D receptor alleles predict growth and bone density in girls. Arch Dis Child. 1998;79:488–494
  31. Krall EA, Parry P, Lichter JB, Dawson-Huges B. Vitamin D receptor alleles and rates of bone loss (influences of years since menopause and calcium intake). J Bone Miner Res. 1995;10:978–984
  32. Pols HAP, Uitterlinden AG, van Leeuwen JPTM. How about vitamin D receptor polymorphism?. Osteoporos Int. 1998;8(Suppl 2):S20–23
  33. Deng HW, Li J, Johnson M, Gong G, Davis M, Recker R. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Hum Genet. 1998;103:576–585
  34. Marc J, Prezelj J, Komel R, Kocijancic A. VDR genotype and response to etidronate therapy in late postmenopausal women. Osteoporos Int. 1999;10:303–306
  35. Blumsohn A, Hannon R, Wrate R, Barton J, al-Dehaimi AW, Colwell A. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol. 1994;40:663–670
  36. Reginster TC, Jayo MJ, Jerome CP. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys. Osteoporos Int. 1997;7:348–353

PII: S0010-7824(02)00432-8

Contraception
Volume 67, Issue 1 , Pages 33-37 , January 2003

Article Tools